Eze, C. et al. 2020. Favorable Outcomes Following the Use of Triple Therapy in a Patient with Osmotic Demyelination Syndrome. Kansas Journal of Medicine. 13, 1 (Jul. 2020), 191–193. DOI:https://doi.org/10.17161/kjm.v13i.13875.